Progenra - The Ubiquitin Company

Home | Contact Us

Therapeutic Focus

Therapeutic Focus

The ubiquitin and UBL pathways contain key regulators of

  • cell cycle progression
  •  protein quality control
  •  immune response
  •  nuclear export of proteins
  • numerous other processes 

Dysregulation of these pathways is associated with

  • neoplastic diseases (cancers)
  •  neurodegenerative diseases
  •  osteoporosis
  •  muscle wasting/cachexia
  • other diseases

web design by JOT Infomedia